(This isn't a requirement for other drugs that plans cover, but obesity has consistently brought up the ROI discussion) --- Of course, your plan will vary depending on the population and implementation, but how are benefits teams thinking about that ~$10 PMPM right now
Five-year, ten-year, twenty-year safety data doesn't exist yet
The Precision Peptide Genetic Test reveals predispositions in peptide pathway genesnot a guaranteed prediction of exact medication response or outcome
METHODS: A total of 120 patients were randomized into three groups
Engelman often recommends Nulastin, a topical formula that supports elastin production around the follicle, helping to maintain a healthier growth environment
In addition to providing GLP-1 medications, we at Set Point also offer comprehensive guidance and support for lifestyle modifications to maximize the potential of these treatments